Greenlane Holdings, Inc. (GNLN) Q1 2019 Earnings Report, Transcript and Summary

Good day, ladies and gentlemen. Thank you for standing by. Welcome to today's conference call to discuss Greenlane Holdings first quarter fiscal 2019 financial results. [Operator Instructions] Hosting today's conference will be Scott Van Winkle with ICR. As a reminder, today's conference is being recorded. And now I would like to turn the conference over to Mr. Van Winkle. Please go ahead, sir.

Thank you, Allie. Good afternoon, and welcome to Greenlane Holdings conference call to discuss results for the first quarter of 2019. On the call today from Greenlane with prepared remarks are Aaron LoCascio, Chief Executive Officer; and Ethan Rudin, Chief Financial Officer. We're also joined by Adam Schoenfeld, our Chief Strategy Officer. By now, everyone should have access to the earnings release, which went out this afternoon at approximately 4:05 p.m. Eastern Time. If you've not received a release, it's available on the Investor Relations portion of Greenlane's website at gnln.com. This call is being webcast, and a replay will be available on the company's website for approximately 30 days. Before we begin, we'd like to remind everyone that Greenlane's prepared remarks contain forward-looking statements, and management may make additional forward-looking statements in response to your questions. These statements do not guarantee future performance, and therefore, undue reliance should not be placed upon them. These statements are based on current expectations of the company's management and involve inherent risk and uncertainties, including those identified in the risk factors included in Greenlane's IPO prospectus dated April 17, 2019. Please note that during today's call, management will discuss non-GAAP financial measures, including adjusted net income and adjusted EBITDA. Management believes these financial measures can facilitate a more complete analysis and greater transparency into Greenlane's ongoing results of operations, particularly when comparing underlying operating results from period to period. Greenlane has included a reconciliation of these non-GAAP measures in today's earnings release. This call also contains time-sensitive information that is accurate only as of the date of this live broadcast, May 9, 2019. Greenlane assumes no obligation to update any forward-looking statement that may be made in today's release or call. Now I will turn the call over to the company's CEO, Aaron LoCascio.

Thanks, Scott, and good afternoon, everyone. We appreciate you joining us for our first conference call as a public company. We enjoyed the opportunity to meet many of you during the course of our IPO road show last month, and look forward to meeting many more of you in the future. On today's call, I will briefly review our first quarter sales highlights, provide an overview of the Greenlane business model, and discuss our growth strategy and business development activities as we continue to build out the industry's leading platform. Ethan will then review our financial results in more detail and discuss our long-term financial targets. After that, we will open up the call for your questions. We're pleased with the first quarter top line performance. We generated $49.9 million of revenue, up 15.3% year-over-year. This growth was particularly impressive given the strong revenue results in the first quarter of 2018. We saw growing popularity and growing availability of our products in both the United States and Canada. The Canadian market represents a rapidly expanding opportunity for us reflecting both the growth of the cannabis market and the nicotine vapor market. In late February, we launched hemp-derived CBD products, and we view the CBD market as a promising new category. We have partnered with leading brands to provide premium hemp-derived CBD products across our platform, initially with Mary's Nutritionals and Select. Additionally, we recently partnered with SLANG Worldwide for distribution across North America. We are very pleased with our growth in supplies and packaging, and in January, we closed on the acquisition of Pollen Gear, a leading producer of premium, patented, child-resistant packaging and an important addition to our portfolio. The acquisition provides incremental margin capture, which should materialize in the second half of this year. Our first quarter performance reflect our strong industry positioning in the fast-growing market for vaporization and consumption accessories. Quite simply, Greenlane is the largest distributor of premium ancillary cannabis and nicotine products in North America, and is well positioned in the large and growing markets for cannabis, e-cigarettes and hemp-derived CBD. Our portfolio spans vaporizers to accessories and packaging, and we distribute via 6 distribution centers in the U.S. and Canada to a diverse base of more than 7,000 wholesale customers representing 11,000-plus physical locations, including independent smoke shops and licensed cannabis companies. We also sell direct to consumers online and through our Higher Standards retail stores. In April, we enhanced our e-commerce capabilities with the launch of Vapor.com. Vapor.com will leverage traffic from our existing sites, and we are marketing the platform offline, including at major cannabis events, to create what we believe will be the leading e-commerce platform in the industry. We are excited for this expansion of our e-commerce capabilities and urge you to visit Vapor.com to see it for yourself. Our success reflects our commitment, experience and unrivaled platform. We've built a reputation for finding and developing the industry's leading premium brands. We offer a one-stop shop providing sales, distribution, customer service and value-added services to our suppliers and brand partners. We truly are the turnkey solution for catering to the end consumer. We have a history of success building brands, and suppliers seek out Greenlane to leverage our expertise. Our brand-building experience includes some of the leading brands in the industry, such as Storz & Bickel, PAX and JUUL, among others. We have also built a portfolio of premium and differentiated house brands, including Marley Natural, Keith Haring, Groove, VIBES, Pollen Gear, Higher Standards and Aerospaced, providing proprietary products at higher margins, while not competing with our core suppliers. Our growth strategies include building upon our strong customer and supplier relationships to drive organic growth, expanding our world-class portfolio of proprietary brands, pursuing value-enhancing acquisitions, growing our e-commerce platform and expanding internationally, including the initial stages of developing our operations in Europe. We made progress on each of these initiatives during the first quarter, including the closing of the acquisition of Pollen Gear, which expanded our portfolio of house brands. We believe Pollen Gear is the clear industry leader in terms of quality and innovation, with a robust portfolio of defensible IP. We expanded organically with new brand partnerships, including the launch of CBD products and the expansion of our portfolio in Canada, hired additional key members of the team, established our entity in Europe and hired our first employee there. We also developed Vapor.com and have numerous opportunities that we are evaluating for further growth. In fact, finding opportunities is not our challenge given our reputation, industry-wide connectivity and dominant positioning in a large and fragmented retail channel. Our greatest challenge is actually determining which opportunities to not pursue. We are building a highly efficient global infrastructure that we believe will create an unrivaled supply chain to support the long-term growth of the cannabis and nicotine vapor industries. Now I'll turn the call over to Ethan to run through the first quarter financial results. Ethan?

Thank you, Aaron, and good afternoon, everyone. First quarter revenue was $49.9 million, representing a 15.3% increase year-over-year. As Aaron noted, the revenue increase was driven primarily by the growing popularity and growing availability of our products in both the United States and Canada. In terms of product categories, the revenue increase compared to the prior year period included increases of $2.7 million in sales related to e-cigarette products, $2.6 million of sales related to child-resistant packaging, and $1 million of sales related to vaporizers and vaporizer accessory products. Gross margin was 18% in the first quarter of 2019 compared to 20.9% in the prior year period, reflecting changes in the sales mix and promotions with a key supplier. On a sequential basis, the gross margin was relatively consistent with the fourth quarter of 2018. Salaries, benefits and payroll tax expenses increased approximately $5.1 million year-over-year primarily due to a onetime expense of approximately $2.9 million of equity-based compensation expense related to the profits -- the conversion of profits' interest in Greenlane's operating company into membership units, and secondarily, due to the addition of 79 employees related to the expansion of domestic sales and marketing efforts. General and administrative expense increased approximately $1.8 million in the first quarter of 2019 due primarily to an increase in marketing expenses, contracted services, executive search and recruitment, new facility expenses and the acquisition of the company's headquarter building as well as expenses related to the acquisition of Pollen Gear, amongst others. Additionally, general administrative expenses included approximately $800,000 of incremental audit and legal fees and consulting expenses related to the company's transition to becoming a public company. Operating loss was $5.2 million compared to operating income of $2.3 million for the first quarter of 2018. Net loss was $17.7 million and was impacted by certain onetime costs, including $12.1 million of expense associated with the change in fair value of our convertible notes, $2.9 million of equity-based compensation expense, $1.2 million of debt placement costs and costs associated with transitioning to a public company. This compares to net income for the first quarter of 2018 of $2.3 million. Adjusted net loss was $1.5 million compared to the adjusted net income of $2.4 million in the prior year. Adjusted net loss for the first quarter of 2019 excludes the previously mentioned expenses and net loss. Adjusted EBITDA was a loss of approximately $800,000 for the first quarter of 2019 compared to a gain of $2.7 million for the comparable period in 2018. We ended the first quarter of 2019 with $2.8 million of cash and $68.8 million of debt. However, on April 23, 2019, subsequent to the end of the quarter, the company completed an initial public offering of 6 million shares, of which 5.25 million shares were offered by the company, raising net proceeds of approximately $80.4 million. In connection with the initial public offering, the convertible notes, which had a balance of $60.3 million and were included in total debt at March 31, 2019, were converted into equity. Assuming the IPO had been completed on March 31, 2019, the company's cash balance would have been $83.2 million, and total debt would have been $8.5 million. Now I will briefly review our long-term financial targets. We're anticipating approximately 25% net annual revenue growth, average gross margins of 20%-plus and adjusted EBITDA margin of 10%-plus. Before I turn the call over to the operator to facilitate questions, I would also like to walk through our share classes. We have 3 share classes: Class A shares, which were sold to IPO investors and which the convertible note holders received upon conversion of those notes; Class B shares, which are held by non-founder members of our operating company; and Class C shares, which are held by our cofounders. The Class C shares are held on a 3:1 basis with respect to the common units of the operating company, and as such, if converted to A shares, 3 Class C shares would be exchanged for 1 Class A share. Class B shares convert on a 1:1 basis. Therefore, our shares outstanding is equal to our outstanding Class A shares plus Class B shares plus 1/3 of our Class C shares. In other words, our shares outstanding is equal to our total shares as if Class B and Class C shares were converted to A shares. This equates to total shares outstanding on an as-converted basis of 41.9 million. Regarding the share sales by existing owners of the company, all share sales were made in connection with the secondary component of the IPO. This consists of 750,000 shares of the total 6 million IPO shares offered that closed on April 23, plus 450,000 shares representing the underwriters' partial exercise of their overallotment option that closed on April 29 for a total of 1.2 million shares. No shares have been sold by insiders outside of the IPO, and all insiders of the company, including management, are subject to a standard 180-day lockup period, during which they are prohibited from selling shares. With that, I will turn the call back over to the operator.

[Operator Instructions] We'll take our first question from Vivien Azer from Cowen.

So I wanted to start off with JUUL, which has obviously been incredibly thoughtful given the fluid regulatory landscape. Can you comment at all, and I apologize if I missed it, on how things are going in Canada? [ Albridge ] certainly flagged it when they reported earnings, but it seems like the market share momentum in stores where JUUL is available has been quite robust.

JUUL sales for the first quarter were $19.1 million representing modest year-over-year growth for our JUUL sales. This increase was primarily driven by strong JUUL sales in Canada, as you mentioned, where flavors are available in all channels and robust sales growth of non-flavored pods in U.S. We've been observing consumers switching to the traditional tobacco and menthol flavors as a result of the flavored pods no longer being available. But specifically to Canada, we haven't -- we're not disclosing the breakout between U.S. and Canada JUUL sales.

Okay. That's fair. But suffice it to say that you're seeing similarly robust like in-store market share consistent with what [ Albridge ] has been disclosing. Is that fair?

Yes. The marketplace for JUUL in Canada has been very strong. It's still very early. But there has been some pretty significant progress made there on the JUUL front.

Okay. Perfect. Second question on CBD, really exciting some of the studio partnerships that you've already been able to ink. On SLANG, can you expand on what that entails?

So SLANG, we have an existing distribution relationship with -- given their other products, namely, the Firefly and Organa brand products. They are working on a number of CBD products as well. I'm not in a position to disclose all of those and what they look like. But they have elected us to be their exclusive supply partner for those products.

Great. That's exciting. Taking kind of a step back on CBD, and I know you guys probably aren't going to be doing annual guidance, but kind of just rough sizing, like how big of a contributor do you think the CBD could be to your full year revenues? And when should we expect those revenues to start kicking in?

So it's very early on the CBD front. We only launched our CBD products in late February. So it's a little too early to tell. That being said, there has been a tremendous positive response for our CBD products, and we're looking to continue to expand on not only the response from the products that we have currently, but on additional products like the SLANG product and a number of others that we're not prepared to talk about just yet, but we're very bullish on CBD.

That's great. And last one for me, and then I'll hop back in the queue. Just on the salary and employee expenses. I heard loud and clear close to $3 million in terms of the onetime expense in calendar 1Q. But given all the new hiring activities, how should we think about that expense line item for the remainder of 2019?

Yes. So we expect there to be -- to continue to see stock-based compensation. That being said, in Q1 of 2019 and also in Q4 of 2018, there were higher-than-usual expenses that were more onetime in nature. So yes, there will be stock-based compensation going forward. But again, not to -- we do not anticipate it being to the degree that we've seen in Q1 of 2019.

We'll take our next question from Derek Dley from Canaccord Genuity.

First of all, congratulations on the successful IPO.

Thank you.

Thanks, Derek.

Just wondering in terms of the launch of Vapor.com, I know it's early days, but can you just talk about the initial customer response and how that has played out in terms of your expectations?

So the first stage in launching Vapor.com is -- or was redirecting traffic from VapeWorld.com, which we have successfully completed. And we spent some time analyzing, watching and learning from the transition of VapeWorld.com to Vapor.com. And I'm pleased to let you know that it was a very successful transition. And now that we've seen the success there, we have initiated our initial offline marketing strategy. Again, very early innings there, and we're continuing now to evaluate rolling in traffic from our other web properties.

And when you mention offline marketing, can you just give us a little bit more color on sort of some of the initiatives that you've got there to drive traffic?

So a couple of initiatives include taking Vapor.com to various cannabis events across the country as well as we've looked at various trade publications, and there's actually a number of them that are currently in circulation right now. Those are a couple of primary examples of that.

Okay. Switching gears a little bit. 2018 was a more heavy capital expenditure year for you guys. Can you just comment on your distribution infrastructure? Are you comfortable with where you're at in the face of what looks like to be some very robust growth upcoming in 2019 and 2020?

Derek, this is Ethan. I would say that we were very, very comfortable with our supply chain, our warehouses. If anything, there'll be some slight modernization of what's going on, on our pick and pack. I know we're taking a look at a couple of vendors who are doing voice and light technology upgrades to make us more efficient in certain regions where we're seeing heavier traffic. But net-net, on the whole, the guidance that we've been giving people going forward on our CapEx is that it should fall anywhere between $1 million to $2 million a year. It's more of a maintenance CapEx figure than anything else. I think if you remember from discussions on the road show and the fourth quarter of '18, our largest CapEx expense was the $10 million we spent on our company headquarters building, and that effectively was rare for us in terms of a CapEx spend.

Right. Okay. And I guess just kind of circling back a little bit, just on that. Given the successful IPO, you guys obviously have a very healthy balance sheet now, minimal CapEx. Can you just talk about some of your capital allocation plans going forward?

Yes. I don't think we've made any -- minced any words, but we are aggressively thinking through an M&A pipeline that actually gets me very, very excited about what's in store for the future. We intend to be the aggregator of choice, the exit of choice, taking advantage of some of that positive connectivity. We're aggressively looking at Europe. We will slowly then and thereafter turn to South America. We're looking at Australia, very, very exciting.

And the last one for me, I guess it's sort of following up on the capital allocation. I get that geographic expansion is important, but can you talk a little bit about your plans in terms of owned brands and increasing the penetration that you do have with your own brands going forward?

Yes. I think when we last talked about the house brands and the penetration of house brands, we said that they represented about 5%, 5.25% of 2018. We've been very, very pleased and have increased that percentage as a percent of revenue of our house brand, especially around Pollen Gear and the supply and packaging. We're really hoping that in the back half of the year, we're going to be using -- driving that as a driver of our margin and getting us closer to the dispensary channel than we already are.

We'll take our next question from Glenn Mattson from Ladenburg Thalmann.

Curious about the early results or returns on the second Higher Standards store. And if your outlook is still the same for about 3 to 5 new stores in 2019.

Great. I'll take that one. Thanks for the question, Glenn. Still early days for us. I think we opened up the Atlanta Higher Standards store in the middle of the road show in April, actually, and we are first starting to see it ramp. And fortunately, as we're watching it ramp, we're seeing the direct result of our marketing efforts show up in the daily revenues. So as far as I'm concerned, we are on track for another 3 to 5 this year.

Okay. Great. That's helpful. And on a different note, with some of the relationships you have, I know some are exclusive and some aren't, but there's a lot of M&A activity in the space, and so I guess maybe can you talk about what happens when some of the brands you are associated with get acquired like Storz & Bickel did by Canopy, or I believe Select got acquired or was announced to be acquired just recently. Can you just give us some color as to the background of the dynamics of what happens in those kind of situations?

Sure. So when companies get acquired like Storz & Bickel, to which we had exclusive distribution in the United States over their products before the acquisition, and maintain that post-acquisition, it's a real testament to, again, just how fragmented the marketplace is. We have 7,000 independent B2B customers that represent 11,000 physical locations. We're very confident that we have the leading distribution footprint. As such, we bring a lot of value to the table on that regard. Select recently announced they were acquired. That was specifically on their THC side. Their CBD side was separated out from that, and we do continue to maintain exclusivity over their CBD product as well.

Okay. Great. That's helpful. And lastly, Ethan, I missed the gross margin target. Could you just repeat what you said there?

Yes. Gross margin over -- yes, long term, we're planning for 20%-plus.

We'll take our next question from Scott Fortune from Roth Capital Partners.

I want to expand upon the kind of the proprietary in-house brands and kind of the different areas that you guys look to target. And is CBD kind of -- platform on that opportunity for you guys, from an in-house type of offering?

This is Adam Schoenfeld, Chief Strategy Officer. We're constantly evaluating white space within the market, right? So when we look at our house brand strategy, it's really centered around creating value propositions for consumers and end users of the product. So in our constant evaluation, I think as we see white spots in the market as it relates to CBD, we'll certainly look to capitalize on them.

Okay. And then a follow on that. With your CBD exclusive agreements, is that opening you up to new potential distribution, new potential stores and retailers from that side of things?

Yes. In both of the agreements, the exclusive agreements we struck with Mary's Nutritionals and Select, there were existing books of business which were inherited by us. There exist, definitely, new accounts in there, and you'll see that our door count has risen since the filing of our prospectus. So yes, we're gaining new doors on all fronts. We're seeing some incremental lift within the stores that we service as it relates to these products, and we're also gaining new doors.

Okay. Great. And then kind of focus on the packaging, custom product side, stemming through on kind of Pollen Gear and how that -- are you able to achieve some new customers from that side and new products within that category kind of what you're looking at?

Sure. So yes, a big part of the Pollen Gear acquisition wasn't just the margin accretion. It was really gaining a strategic team. So the Pollen Gear team is actually a team of storied industrial designers that have had a tremendous track record and career building successful consumer offerings. So for us, it was highly strategic because the transaction gave us a foundational design team based in Hermosa Beach, California where we maintain a design studio, to be able to apply their industrial design acumen across all categories of the business. So yes, we are leveraging that design team across all categories. There's a whole host of innovation on all fronts, and we're constantly innovating on the packaging front. So there are many new products that we expect to release across-the-board.

Okay. And last question from an international standpoint. I know Europe is new. Can we expect anything much from a revenue standpoint towards the second half of the year from Europe? And then kind of expectation as Canada comes on board with cannabis 2.0, and you had a both base market going forward here.

Sure. So I think we're incredibly bullish on all of the international markets. I think that they're catching up in terms of consumer habits, globally, especially in Europe. So we're -- right now, we're laying foundation. It's really for us all about positive connectivity, building out the relationships on all fronts, right? So we see a tremendous opportunity to articulate our products and offerings into these new markets, and we're moving very deliberately. So we're moving in a way that is short of creating value proposition for the new customers that we're bringing on board, and we're very focused on long-term growth in those markets.

And we'll take our next question from Mike Grondahl from Northland Capital Markets.

This is Mike Pochucha on for Mike Grondahl. Maybe just first going back to Higher Standards, is there any product or category that really call out in the quarter that was trending positively?

Specifically related to Higher Standards product as a product line? Or Higher Standards the stores?

Just as a store. It seemed like the full transaction down to the end consumer.

Yes. So one of the reasons why we're very bullish on CBD is because we are seeing tremendous velocity for our CBD products in our Higher Standards stores. Behind that, JUUL remains a very strong product line as well.

And then maybe just on -- a couple of weeks ago, some positive news with Philip Morris and their IQOS system. Any thoughts on that, how that kind of fits in the market?

So I'm a huge advocate. We all are huge advocates for vaporization as a technology, which includes the IQOS product. So it's always very exciting to see new technology and innovation come to the market because we're advocates for adult use of vaping products over cigarettes, and we continually evaluate new products for distribution into our channels. With respect to IQOS and how it may or may not affect our sales in JUUL, we see them as very distinctly different products. So we do not anticipate any changes to the velocity of JUUL given the launch of that product. And again, being the leader in an incredibly fragmented marketplace, if we're provided the opportunity to distribute that product to our customers as well, that's something that we'd be very happy to evaluate.

We'll take our next question from Vivien Azer from Cowen.

Given your presence in Canada on the cannabis side, I was just wondering if you could comment at all around the state of category development and how that's impacting your discussions with LPs in terms of their resource requirements. It seems from the publicly available data that perhaps the category is getting off to a bit of a slower start than had been anticipated. Do you think that that's adequately reflected in your internal planning?

Sure, Vivien. This is Adam Schoenfeld. So yes, we're -- I've actually just returned from Toronto just now. A lot of our LP customers, they're obviously watching the October date for vaping products to come online. I think things are good on all fronts there. It's been a little bit slower of a ramp-up on -- with certain LPs. But we're continuing to see pretty strong interest across all of our categories, be it consumer packaged goods, child-resistant packaging as well as vapor product in the Canadian marketplace.

We'll take our last question from Rohan Abrol from Cedar Holdings.

A question for you on Vapor.com. I guess I've been pondering whether you guys have any plans to roll out a direct-to-consumer subscription service there. And if so, whether you might go at it alone organically or do that via partnership.

Sure. Great question. So yes. Vapor.com, we have a fairly robust strategy, and we touched earlier on taking marketing offline. I think there are a whole host of post-transactional opportunities that will lend themselves to greater lifetime customer value. We're constantly evaluating all means of connecting with customers and retaining them as customers. The subscription model is something we're keenly aware of and actively working on. As for whether or not we would partner with others or build it ourselves, I think it's a little early to opine on that one.

Okay. Understandable. And I guess with respect to your long-term targets, do you have a rough figure in mind for where you'd like to see that 5.25% contribution from house brands trend over the next few years?

So as we evaluate house brands versus our other core segments, we're really focused in 3 particular areas, which includes our B2C segments, our supplies and packaging segment and our house brands as it relates to all of our segments, including those 2 and our primary core segment of B2B. Because those 3 particular segments are higher-margin categories for us, therefore, they provide a disproportionate impact to our bottom line. So any combination of increase across the 3 of them is regarded as a success to us. So I don't want to speak specifically to where we anticipate B2C to end up versus supply and packaging. It's really about the combination of those 3 being successful.

Got you. Got you. And then are there any nuances we should be considering now when modeling for seasonality here?

There is some seasonality to our business. The summer months, in particular, are generally regarded as slower months in the industry. That being said, they're often masked by growth. So it's a little bit difficult to call out seasonality with that in mind.

Makes sense. Do you happen to have any relationship with Walmart? And I ask in light of their recent comments around voluntarily raising the rates -- raising the age there to purchase e-cigarettes.

Yes. For e-cigarettes, we're in the independent channel, and it's just not something we've been discussing these days with big-blocks retailers in the U.S.

Okay. And you aren't disclosing Canadian revenue contribution as a proportion of 1Q, right?

We are, but not specific to any particular product. So in Canada for our first quarter 2019, it was approximately $6.8 million of revenue compared to approximately $1.9 million of revenue for Q1 of 2018, which represents an increase of $4.9 million or 258%. Sales in Canada overall represented 14% of the total net sales in Q1.

Got you. And I mean the $19.1 million figure you threw out there earlier on JUUL-related revenue contribution was pretty strong, at least from how I was modeling how you guys performing in 1Q. So just curious as I think about devices kind of your general menthol and tobacco pod sales and then your flavored pod sales, is there any one specific category there that kind of surpassed your internal expectations or was driving that figure?

It was -- the growth in JUUL was specifically -- again, surprising, absolutely, a little bit surprising to the upside...

That's true. Yes.

For us as well, and it was a combination of the success of the product in Canada as well as a lot of consumers switching from the core -- the flavored products to the core tobacco products in the U.S. and more users continuing to make the switch from combustion products to products like JUUL. A combination of those things resulted in an increase overall. And then JUUL added a promotion on top of it, which is pretty common. They run promotions pretty frequently. So that's -- certainly didn't hurt the equation either.

Got you. And in terms of the, call it, $1 million increase in year-over-year sales related to vaporizers and vaporizer accessory products, is that largely PAX-derived sales? How should I be thinking about that?

That's across-the-board. It's across the whole vaporizer portfolio.

And we have no further questions. And I'd like to hand the call back over to Mr. LoCascio for any additional or closing remarks.

I wanted to say thank you for joining us today. We really appreciate your support, and we're excited to have embarked on this next phase of Greenlane's growth. We'll be presenting at the Canaccord Conference next week in New York, and Cowen's Conference in 2 weeks in Toronto. And we hope to see some of you there. Have a great day.

And that does conclude today's conference. Thank you for your participation. You may now disconnect.